HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

corbrin

the essential component of corbrin is fermented dry powder of the hyphae of Cordyceps sinensis; exhibits antiinflammation, antirejection, immunosystem and leukocyte protection effect
Also Known As:
corb
Networked: 5 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Hu, Rong: 2 articles (09/2013 - 09/2012)
2. Girdwood, J: 1 article (06/2014)
3. Janus, E: 1 article (06/2014)
4. Williams, E: 1 article (06/2014)
5. Karunajeewa, H: 1 article (06/2014)
6. Bai, Hai-Bo: 1 article (09/2013)
7. Fu, Xu-Chun: 1 article (09/2013)
8. Qian, Ying: 1 article (09/2013)
9. Shen, Li-Mei: 1 article (09/2013)
10. Shen, Li-mei: 1 article (09/2012)

Related Diseases

1. Fibrosis (Cirrhosis)
09/01/2013 - "Corbrin Shugan capsule is effective in treatment of DMN-induced hepatic fibrosis in rats."
09/01/2012 - "To investigate the therapeutic effect of Corbrin shugan capsule for treatment of alcoholic hepatic fibrosis in rats. "
09/01/2012 - "[Corbrin shugan capsule for treatment of alcoholic hepatic fibrosis in rats]."
09/01/2013 - "Compared to model group the high-dose (450 mg kg(-1)),mid-dose (270 mg kg(-1)) and low-dose (90 mg kg(-1)) groups of Corbrin Shugan capsule had significantly lower serum content of III PC [34.46 ± 13.95),(36.15 ± 9.46), and (40.58 ± 7.72)ng ml(-1) compared with (49.38 ± 10.95)ng ml(-1),P<0.05 or P<0.01],TIMP-1 [(16.65 ± 4.24),(16.66 ± 4.34),and (18.99 ± 6.05)ng ml(-1) compared with (30.84 ± 14.48)ng ml(-1), P<0.05 or P<0.01], LN [(12.94 ± 4.29), (12.96 ± 3.21),and (15.32 ± 8.00)ng ml(-1) compared with (30.22 ± 17.00)ng ml(-1),P<0.05 or P<0.01] and smaller hepatic fibrosis area [(0.02240 ± 0.01337), (0.02176 ± 0.01460) and (0.02384 ± 0.01405)μm(2) compared with vs (0.03929 ± 0.01732)μm2, P<0.05 or P<0.01]; the high-dose and mid-dose groups of Corbrin Shugan capsule had significantly lower content of Hyp in liver tissues [(0.77 ± 0.09) and (0.81 ± 0.09)μg μmg(-1) compared with (1.06 ± 0.33)μg mg(-1),P<0.05 or P<0.01]; and the high-dose group of Corbrin Shugan capsule significantly increased the content of ALB in sera [(34.02 ± 4.17)g L(-1) compared with (30.25 ± 4.21)g L(-1),P<0.05]. "
09/01/2013 - "To investigate the effects of Corbrin Shugan capsule on dimethylnitrosamine (DMN)-induced hepatic fibrosis in rats. "
2. Osteoid Osteoma
3. Pneumonia (Pneumonitis)

Related Drugs and Biologics

1. Tissue Inhibitor of Metalloproteinase-1
2. Tissue Inhibitor of Metalloproteinases (TIMP)
3. Dimethylnitrosamine (Nitrosodimethylamine)